Showing 145 news articles about Resistance

Filters Content type: Editors' picks Topic: Resistance

Poor adherence and the subsequent development of drug resistance is one reason why HIV treatment can fail. A drug-resistant HIV strain is one which is less susceptible to the effects of one or more anti-HIV drugs.

Sexually transmitted infections prevention

DoxyPEP Use Linked to Increased High-Level Tetracycline Resistance in Neisseria gonorrhoeae

Editor's pick
Contagion Live
26 November 2025
Resistance

New WHO framework aims to tackle rising resistance to HIV, STI, and hepatitis treatments

Editor's pick
CIDRAP
26 November 2025
Resistance

New Data Support Lenacapavir for Treatment-Experienced HIV

Editor's pick
Medscape (requires free registration)
26 November 2025
New & experimental HIV treatments

Lenacapavir drug resistance in phase 1b study

Editor's pick
i-Base
25 November 2025
New & experimental HIV treatments

Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings

Editor's pick
FiercePharma
17 November 2025
Resistance

HIV Drug Resistance Is Declining Over Time

Editor's pick
POZ
25 September 2025
Injectable & long-acting HIV treatment

Potential for bictegravir and dolutegravir to overcome resistance to CAB/RPV-LA

Editor's pick
i-Base
14 April 2025
Sexually transmitted infections epidemiology

CDC’s top laboratory on sexually transmitted diseases is shut by Trump administration

Editor's pick
STAT
7 April 2025
Resistance

Widely used HIV drug in South Africa flagged for reports of resistance – but experts say don’t panic

Editor's pick
Spotlight
16 April 2024
Resistance

New report documents increase in HIV drug resistance to dolutegravir

Editor's pick
World Health Organization
6 March 2024
Resistance

FDA Expands Indication for Biktarvy to for Resistant HIV

Editor's pick
Infectious Disease Special Edition
1 March 2024
Resistance

U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy® to Treat People with HIV with Suppressed Viral Loads, Pre-existing Resistance

Editor's pick
Gilead Sciences press release
27 February 2024
How HIV works

Higher viral load during HIV infection can shape viral evolution

Editor's pick
EurekAlert!
10 January 2024
PrEP science

Resistance Mutation Associated With PrEP Use in People Newly Diagnosed With HIV in New York City

Editor's pick
TheBodyPro
5 January 2024
Resistance

History of PrEP Use Linked to M184I/V Mutation at HIV Diagnosis

Editor's pick
Infectious Disease Advisor
22 December 2023
Injectable & long-acting HIV treatment

Top 10 HIV Clinical Developments of 2023

Editor's pick
TheBodyPro
1 December 2023
People with limited treatment options

Study Bite: Switching to B/F/TAF Plus Doravirine in Multidrug-Resistant PLWH

Editor's pick
TheBodyPro
5 May 2023
Resistance

Treating HIV? Memorize These 12 HIV Resistance Mutations. Yes, Really.

Editor's pick
TheBodyPro
23 February 2023
Injectable & long-acting HIV treatment

FDA Approves New HIV Drug for Adults with Limited Treatment Options

Editor's pick
FDA
22 December 2022
Changing treatment

A Switch to B/F/TAF Keeps HIV Suppressed, Even With Mutation

Editor's pick
Medscape (requires free registration)
20 September 2022
Resistance

HIV patients in Botswana get adequate treatment but not all of them – one group is slipping through the cracks

Editor's pick
The Conversation
6 September 2022
Resistance

Fostemavir Improves Outcomes for Treatment-Resistant HIV Patients

Editor's pick
Contagion Live
1 August 2022
New & experimental HIV treatments

Fostemsavir Plus Optimized Background Therapy May Be Viable for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
30 June 2022
Treatment guidelines

Act now to tackle HIV drug resistance, WHO urges

Editor's pick
Avert
10 January 2022